Design and rationale of the Danish trial of beta-blocker treatment after myocardial infarction without reduced ejection fraction: study protocol for a randomized controlled trial.

Anna Meta Dyrvig KristensenAnn BovinAnn Dorthe ZwislerCharlotte CerquiraChristian Torp-PedersenHans Erik BøtkerIda GustafssonKarsten Tange VeienKristian Korsgaard ThomsenMichael Hecht OlsenMogens Lytken LarsenOlav Wendelboe NielsenPer HildebrandtSussie FoghmarSvend Eggert JensenTheis LangeThomas SehestedTomas JernbergDan AtarBorja IbanezEva Prescott

Published in: Trials (2020)

Clinicaltrials.gov, NCT03778554. Registered on 19 December 2018. European Clinical Trials Database, 2018-002699-42, registered on 28 September 2018.

Keyphrases

clinical trial
phase ii
phase iii
study protocol
emergency department
open label
angiotensin converting enzyme
angiotensin ii